Publications by authors named "Y Ipek"

Harmful algal blooms (HABs) are often linked to the increased loading of limiting nutrients such as nitrogen and phosphorus. Little is known about the relevance of other biogenic elements, the supplies of which are spatiotemporally heterogeneous, on HABs. We measured the dissolved, bioavailable, and particulate concentrations of 26 elements at four locations draining different catchments of a large reservoir during three seasons, in addition to the total abundance of phytoplankton and % of cyanobacteria.

View Article and Find Full Text PDF

Plant-derived bioactive substances have demonstrated significant qualities that suggest they may be crucial in preventing various chronic diseases. Flavonoids, which include apigenin, are the biggest group of polyphenols. In our study, we aimed to obtain the methanol-chloroform (1:1) extract from the aerial parts of Hedge & Lamond and purify the apigenin using bioactivity-guided isolation to separate the active fraction.

View Article and Find Full Text PDF

Turtle acanthocephalans in the genus Neoechinorhynchus have complex life cycles and are thought to involve an ostracod intermediate host and a turtle definitive host. For Neoechinorhynchus emydis, an additional snail paratenic host is part of its life cycle. However, how snails become infected and whether other species of Neoechinorhynchus can be found in snails remains unclear.

View Article and Find Full Text PDF

BCR::ABL1-negative myeloproliferative neoplasms (MPNs) pose a substantial risk of thrombosis, leading to significant morbidity and mortality. Anticoagulant therapy, historically based on vitamin K antagonists (VKAs), has limitations in preventing recurrent thrombotic events and managing bleeding complications. Direct oral anticoagulants (DOACs) offer a potential alternative with improved pharmacokinetics and compliance.

View Article and Find Full Text PDF

Acute myeloid leukemia and myelodysplastic syndrome are both clonal hematologic malignancies that primarily affect older adults. Current treatments for AML/MDS are both limited in number and efficacy. This study aims to evaluate venetoclax-based therapies in AML/MDS, focusing on overall survival and recurrence-free survival rates, and to expand real-world data on its use.

View Article and Find Full Text PDF